2nd Quarter - Report

PALANTIR TECHNOLOGIES, INC. for PALANTIR TECHNOLOGIES INC.

Firm
Client
Income
—
Expenses
$730,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Budget/Appropriations BUD

FY24 Department of Homeland Security (DHS) appropriations; FY24 Financial Services and General Government appropriations - funding for Office of National Drug Control Policy (ONDCP)/High Intensity Drug Trafficking Areas (HIDTA); FY24 Department of Health and Human Services (HHS) appropriations - funding for healthcare programs, including funding for Food and Drug Administration, National Institutes of Health N3C Program, and Centers for Disease Control and Prevention, the Ready Response Data Integration Platform; FY24 Agriculture, Rural Development, Food and Drug Administration appropriations, including 21 Forward Program at FDA

LobbyistCovered position, as disclosed
AMANDA (MANDI) L. MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Government Issues GOV

IT acquisition reform; Broader commercial item preference; Deployment of the Palantir Government software platform in defense and civilian organizations; Federal Aviation Administration (FAA) Reauthorization Act; Pandemic All-Hazards Preparedness Act reauthorization

LobbyistCovered position, as disclosed
AMANDA (MANDI) L. MILLER —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Defense DEF

H.R 2670, the National Defense Authorization Act of 2024; S. 2226, the National Defense Authorization Act of 2024; Department of Defense Appropriations Bill of 2024

LobbyistCovered position, as disclosed
ABBEY OVERLAND —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 2226 (118th), H.R. 2670 (118th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.